| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | — | — | — | — | — | — |
| 3d | — | — | — | — | — | — |
| 1w | — | — | — | — | — | — |
| 1m | — | — | — | — | — | — |
| 3m | — | — | — | — | — | — |
| 6m | — | — | — | — | — | — |
| 1y | — | — | — | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
TD Bank trades at a justified premium to book value with a strong fundamental position; post-regulatory fines, it stands to benefit from anticipated lower interest rates and stable political environments in the US and Canada.
Ecopetrol offers compelling value with strong operating margins, a solid balance sheet, a sub-5 P/E ratio, and an 18% dividend yield, though geopolitical risk in Colombia is a consideration for risk-averse investors.
Pfizer trades at a reasonable forward P/E of 18 with a sustainable dividend yield, patent portfolio, and financial capacity to pursue new growth opportunities, making it a solid value holding.
End of results.